Initially, NADPH-oxidase-derived ROS production was also implicated in IL-1β release in the periodic fever cryopyrin-associated periodic syndrome, but analyses of chronic granulomatous disease patients discounted a role for NADPH-oxidases in these disorders (16, 17). The gene discussed is FMO5; the disease is chronic granulomatous disease.